COLO-PREDICT: Digital Training and Optical Diagnosis of Colorectal Polyps

Recruiting Observational Study
Colorectal Polyps
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Clinique Paris-Bercy · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Colorectal cancer prevention relies on high-quality colonoscopy and accurate optical characterization of colorectal polyps. Optical diagnosis may allow optimization of management strategies such as resect-and-discard for diminutive polyps, potentially improving efficiency in routine practice. COLO-PREDICT is a prospective, single-center, observational study designed to evaluate the impact of a st…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged ≥18 years * Patients undergoing colonoscopy in routine clinical practice at the participating center * At least one colorectal polyp detected during colonoscopy * Optical histology prediction recorded during the procedure * Histopathological analysis available for …
Contacts

David Karsenti, MD

+33145486565

karsenti.paris@gmail.com

CONTACT

Coralie Declerck, Ms.

c.declerck@clinique-bercy.fr

CONTACT